摘要
目的:探究参麦注射液配合瑞通立溶栓对前壁急性心肌梗死(AMI)患者心肌再灌注损伤的保护作用。方法:择取前壁AMI患者88例,随机划分为对照组与观察组,给予对照组44例患者瑞通立溶栓治疗,给予观察组44例患者瑞通立溶栓加参麦注射液治疗,比较两组的溶栓效果及预后差异。结果:干预后,观察组的临床有效率(95.45%)较对照组(75.00%)明显升高(P<0.05);两组的LVEDD及LVEF明显升高,且以观察组变化更为明显(P<0.05)。虽然观察组的溶栓再通率稍高于对照组,不良心血管事件发生率稍低于对照组,但比较无显著性统计学差异。结论:参麦注射液配合瑞通立溶栓可减轻前壁AMI患者心肌再灌注损伤,保护患者的心功能,对于提高患者的预后有积极作用。
Objective：To explore the effect of Shenmai injection combined with Riton vertical thrombolysis on acute anterior myocardial infarction（AMI）patients with protective effect on myocardial reperfusion injury.Methods：Choosed 88 patients with anterior wall AMI,were randomly divided into control group and observation group,44 patients in the control group were given Riverstone state thrombolytic therapy,44 patients in observation group were given thrombolysis Riverstone state＋ Shenmai injection therapy,thrombolytic effect and prognosis were compared between the two group.Results：After the intervention,the clinical effective rate of observation group（95.45%）than in the control group（75%）was significantly higher（P〈0.05）;LVEDD and LVEF of two groups increased significantly,and the observation group increased more obviously（P〈0.05）;although the thrombolytic recanalization rate in observation group was slightly higher than that of control group.The occurrence rate of adverse cardiovascular events was slightly lower than the control group,but no significant difference（P〈0.05）.Conclusion：Shenmai injection combined with thrombolysis can reduce myocardial Riverstone state before patients wall AMI reperfusion injury,protect the heart function of patients,to improve the prognosis of patients with positive role.
出处
《陕西中医》
2017年第2期171-173,共3页
Shaanxi Journal of Traditional Chinese Medicine
关键词
前壁心肌梗塞
心肌再灌注损伤/中西医结合疗法
参麦注射液/治疗应用
Anterior wall myocardial infarction
Myocardial reperfusion injury/integrated Chinese traditional and western medicine therapy
Shen Mai Zhu She Ye/therapeutic uses
